ArticleMaterials (Basel, Switzerland)2023
Study of the Soft Magnetic Properties of FeSiAl Magnetic Powder Cores by Compounding with Different Content of Epoxy Resin.
Article in Materials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- High-frequency FeSiAl-based soft magnetic composites via simultaneously suppressed eddy and hysteresis losses.Nature communications · 2025Article
- Special Issue: "Soft Magnetic Materials and Their Applications".Materials (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
FeSiAl is a commonly used soft magnetic material because of its high resistivity, low core loss, and low cost. In order to systematically study the effect of epoxy resin (EP) on the insulated coating and pressing effect of FeSiAl magnetic powders, six groups of composite powders and their corresponding soft magnetic powder cores (SMPCs) were prepared by changing the content of EP, and the soft magnetic properties of the powders and SMPCs were characterized. The results showed that FeSiAl powders exhibited good sphericity and morphology. The
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.